Alkyl Amines Chemicals Ltd
Alkyl Amines Chemicals Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Volume growth in H1 FY'26 was marginally up but below the usual 10-15% annual growth expectation due to subdued demand. The first half of FY'26 has been subdued with marginal volume growth and flat topline due to demand pressures and geopolitical factors. - Volume growth expected to be lower than the usual 10-15% for FY'26. - Margins have been protected despite pricing pressures. - Demand is currently subdued across agrochemicals, pharma, and other industries but may improve if global trade volatility settles. - Capacity expansions, such as the new plant with a CAPEX of ~Rs.
From Alkyl Amines Chemicals Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Volume growth in H1 FY'26 was marginally up but below the usual 10-15% annual growth expectation due to subdued demand.
- Full year FY'26 volume growth is expected to remain subdued owing to global geopolitical and trade challenges.
- Demand in methylamines impacted more than ethylamines, with ethylamines focused more on the domestic market.
- Capacity utilization and demand growth for products like acetonitrile depend on market conditions; capacity expansion decisions will be made once utilization nears limits.
- New product launches are expected by early 2026-27, with positive outlook on profitability and potential import substitution.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Alkyl Amines Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Alkyl Amines Chemicals has ongoing capital expenditure at Kurkumbh for a new product, expected to be mechanically completed between February-March 2026, with commercialization in Q1 of FY 2026-27.
- The CAPEX for this new product is approximately Rs. 120 crores.
- This product targets dyes, pigments, electronics sectors and serves as an import substitute, with no current domestic competitor.
- Asset turnover expected for this new product is about 1.5 times.
- For acetonitrile (ACN), potential future capacity expansion depends on market growth and capacity utilization; no immediate CAPEX decisions will be made until utilization justifies it.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Alkyl Amines Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Alkyl Amines Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹387 Cr, net profit ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Alkyl Amines Chemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Bodal Chemicals Ltd (Q2 FY26)
Q2 FY26 consolidated revenue from operations: Rs 4,804.5 mn, up 11.2% YoY from Rs 4,321.2 mn (Page 10). Key concall takeaways from Bodal Chemicals Ltd's Q2…
- Chemcon Speciality Chemicals Ltd (Q2 FY26)
Q2 FY26 revenue from operations: ₹53.7 crore, up 2% YoY (vs ₹52.6 crore in Q2 FY25) [Page 9, 6] . Key concall takeaways from Chemcon Speciality Chemicals Ltd's…
- Valiant Organics Ltd (Q2 FY26)
Q2-FY26 consolidated revenue from operations: INR 1,573 million, down 1.8% year-on-year (Page 12). Key concall takeaways from Valiant Organics Ltd's Q2 FY26…
- Indian Phosphate Ltd (Q2 FY26)
H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25. Key concall takeaways from Indian Phosphate's Q2 FY26 earnings call…
Frequently Asked Questions
What were Alkyl Amines Chemicals Ltd Q2 FY26 results?
Volume growth in H1 FY'26 was marginally up but below the usual 10-15% annual growth expectation due to subdued demand. The first half of FY'26 has been subdued with marginal volume growth and flat topline due to demand pressures and geopolitical factors. - Volume growth expected to be lower than the usual 10-15% for FY'26. - Margins have been protected despite pricing pressures. - Demand is currently subdued across agrochemicals, pharma, and other industries but may improve if global trade volatility settles. - Capacity expansions, such as the new plant with a CAPEX of ~Rs.
What is Alkyl Amines Chemicals Ltd share price analysis?
Alkyl Amines Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 44.1 with a market cap of ₹9,921 Cr. Investors should review the full earnings analysis for detailed insights.
Is Alkyl Amines Chemicals Ltd planning capital expenditure?
Alkyl Amines Chemicals has ongoing capital expenditure at Kurkumbh for a new product, expected to be mechanically completed between February-March 2026, with commercialization in Q1 of FY 2026-27. - The CAPEX for this new product is approximately Rs.
Keep Alkyl Amines Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.